121 related articles for article (PubMed ID: 4019272)
21. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
[TBL] [Abstract][Full Text] [Related]
22. Hypoxic cell sensitizers and heavy charged particle beams may play complementary roles in killing hypoxic tumor cells.
Curtis SB; Tenforde TS; Afzal SM
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1203-5. PubMed ID: 6432747
[TBL] [Abstract][Full Text] [Related]
23. Clinical experience with intravenous misonidazole for carcinoma of the esophagus: results in attempting radiosensitization of each fraction of exposure.
Schwade JG; Kinsella TJ; Kelly B; Rowland J; Johnston M; Glatstein E
Cancer Invest; 1984; 2(2):91-5. PubMed ID: 6733563
[TBL] [Abstract][Full Text] [Related]
24. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycin.
Tannock IF
Br J Cancer; 1980 Dec; 42(6):861-70. PubMed ID: 7459220
[TBL] [Abstract][Full Text] [Related]
25. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
Siemann DW
Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
[TBL] [Abstract][Full Text] [Related]
26. Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069.
Siemann DW; Maddison K; Wolf K
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1657-60. PubMed ID: 6548212
[TBL] [Abstract][Full Text] [Related]
27. The value of combining the radiosensitizer misonidazole with cyclophosphamide in treating the murine Lewis lung tumor.
Pedersen JE; Barron G; Meeker BE
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):651-3. PubMed ID: 7107392
[TBL] [Abstract][Full Text] [Related]
28. Effects of single and combined maltose tetrapalmitate immunotherapy, cyclophosphamide chemotherapy and radiotherapy on ethyl carbamate accelerated primary lung cancer in A/J mice.
Benrezzak O; Madarnas P; Pageau R; Nigam VN
In Vivo; 1988; 2(2):159-65. PubMed ID: 2979834
[TBL] [Abstract][Full Text] [Related]
29. Time-dose relationships for simultaneous misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea exposures in vitro.
Mulcahy RT; Dembs N
Cancer Res; 1983 Aug; 43(8):3539-43. PubMed ID: 6861127
[TBL] [Abstract][Full Text] [Related]
30. Nitrosourea-misonidazole combination chemotherapy: effect on KHT sarcomas, marrow stem cells and gut.
Mulcahy RT; Siemann DW; Sutherland RM
Br J Cancer; 1982 Jun; 45(6):835-42. PubMed ID: 6212075
[TBL] [Abstract][Full Text] [Related]
31. The therapeutic potential of misonidazole enhancement of alkylating agent cytotoxicity.
Hirst DG; Brown JM
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):639-42. PubMed ID: 7107389
[TBL] [Abstract][Full Text] [Related]
32. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
Ohizumi Y; Murayama C; Maezawa H; Mori T
Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
[TBL] [Abstract][Full Text] [Related]
33. In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
Siemann DW
Br J Cancer; 1981 Mar; 43(3):367-77. PubMed ID: 7225287
[TBL] [Abstract][Full Text] [Related]
34. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
Law MP; Hirst DG; Brown JM
Br J Cancer; 1981 Aug; 44(2):208-18. PubMed ID: 7272187
[TBL] [Abstract][Full Text] [Related]
35. Clinical trials with cyclophosphamide and misonidazole combination for maintaining treatment after radiation therapy of lung carcinoma.
Busutti L; Breccia A; Stagni G; Gattavecchia E
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1739-43. PubMed ID: 6480456
[TBL] [Abstract][Full Text] [Related]
36. High dose misonidazole with dexamethasone rescue: a possible approach to circumvent neurotoxicity.
Urtasun RC; Tanasichuk H; Fulton D; Agboola O; Turner AR; Koziol D; Raleigh J
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):365-9. PubMed ID: 7107353
[TBL] [Abstract][Full Text] [Related]
37. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.
Tannock IF
Br J Cancer; 1980 Dec; 42(6):871-80. PubMed ID: 7459221
[TBL] [Abstract][Full Text] [Related]
38. Nitroheterocyclic compounds as radiation sensitizers and bioreductive drugs.
Adams GE; Stratford IJ; Bremner JC; Edwards HS; Fielden EM
Radiother Oncol; 1991; 20 Suppl 1():85-91. PubMed ID: 2020774
[No Abstract] [Full Text] [Related]
39. Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trial.
Urtasun R; Feldstein ML; Partington J; Tanasichuk H; Miller JD; Russell DB; Agboola O; Mielke B
Br J Cancer; 1982 Jul; 46(1):101-8. PubMed ID: 6285947
[TBL] [Abstract][Full Text] [Related]
40. The combination of 5-fluorouracil with misonidazole in patients with advanced colorectal cancer.
Spooner D; Bugden RD; Peckham MJ; Wist EA
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):387-9. PubMed ID: 7107357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
